These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 10828055

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII.
    Freeman BJ, Roberts MS, Vogler CA, Nicholes A, Hofling AA, Sands MS.
    Blood; 1999 Sep 15; 94(6):2142-50. PubMed ID: 10477745
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII.
    Sands MS, Erway LC, Vogler C, Sly WS, Birkenmeier EH.
    Blood; 1995 Sep 01; 86(5):2033-40. PubMed ID: 7655032
    [Abstract] [Full Text] [Related]

  • 6. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse.
    Meng XL, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y.
    J Neurosci Res; 2003 Oct 15; 74(2):266-77. PubMed ID: 14515356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lentiviral-mediated gene therapy results in sustained expression of β-glucuronidase for up to 12 months in the gus(mps/mps) and up to 18 months in the gus(tm(L175F)Sly) mouse models of mucopolysaccharidosis type VII.
    Derrick-Roberts AL, Pyragius CE, Kaidonis XM, Jackson MR, Anson DS, Byers S.
    Hum Gene Ther; 2014 Sep 15; 25(9):798-810. PubMed ID: 25003807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII.
    Bielicki J, McIntyre C, Anson DS.
    Mol Genet Metab; 2010 Dec 15; 101(4):370-82. PubMed ID: 20864369
    [Abstract] [Full Text] [Related]

  • 11. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow cells.
    Maréchal V, Naffakh N, Danos O, Heard JM.
    Blood; 1993 Aug 15; 82(4):1358-65. PubMed ID: 8353294
    [Abstract] [Full Text] [Related]

  • 12. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C, Levy B, Galvin NJ, Thorpe C, Sands MS, Barker JE, Baty J, Birkenmeier EH, Sly WS.
    Pediatr Res; 1999 Jun 15; 45(6):838-44. PubMed ID: 10367775
    [Abstract] [Full Text] [Related]

  • 13. Neonatal retroviral vector-mediated hepatic gene therapy reduces bone, joint, and cartilage disease in mucopolysaccharidosis VII mice and dogs.
    Mango RL, Xu L, Sands MS, Vogler C, Seiler G, Schwarz T, Haskins ME, Ponder KP.
    Mol Genet Metab; 2004 May 15; 82(1):4-19. PubMed ID: 15110316
    [Abstract] [Full Text] [Related]

  • 14. Gene therapy for murine mucopolysaccharidosis type VII.
    Sands MS, Wolfe JH, Birkenmeier EH, Barker JE, Vogler C, Sly WS, Okuyama T, Freeman B, Nicholes A, Muzyczka N, Chang PL, Axelrod HR.
    Neuromuscul Disord; 1997 Jul 15; 7(5):352-60. PubMed ID: 9267850
    [Abstract] [Full Text] [Related]

  • 15. Correction of murine mucopolysaccharidosis type VII (MPS VII) by bone marrow transplantation and gene transfer therapy.
    Birkenmeier EH.
    Hum Gene Ther; 1991 Jul 15; 2(2):113. PubMed ID: 1911931
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of a lysosomal storage disease, mucopolysaccharidosis VII, with microencapsulated recombinant cells.
    Ross CJ, Bastedo L, Maier SA, Sands MS, Chang PL.
    Hum Gene Ther; 2000 Oct 10; 11(15):2117-27. PubMed ID: 11044913
    [Abstract] [Full Text] [Related]

  • 17. Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice.
    Gao C, Sands MS, Haskins ME, Ponder KP.
    Mol Ther; 2000 Sep 10; 2(3):233-44. PubMed ID: 10985954
    [Abstract] [Full Text] [Related]

  • 18. Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts.
    Moullier P, Bohl D, Heard JM, Danos O.
    Nat Genet; 1993 Jun 10; 4(2):154-9. PubMed ID: 8348154
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.